The UK’s first international prescribing service has launched for medical cannabis patients travelling to the country from overseas.
New findings suggest promise for CBN in treating neurological disorders like traumatic brain injury, Alzheimer’s disease, and Parkinson’s disease.
Researchers evaluated the effect of recreational cannabis legalisation and retail sales on use of cannabis, tobacco, and alcohol.
A crowdfunder aims to raise £20,000 to undertake public relations and promotional activity around the existence and benefits of prescription cannabis.
The move will enable individuals with conditions such as anxiety, ADHD or PTSD to access treatment through Treat It clinic.
The pilot in canton Zurich will include up to 7,500 participants and is the first to include a randomised control trial as part of the research.
The first study of its kind has found cannabis to be beneficial in the treatment of female orgasm disorder.
Cash has described CBD as a ‘gamechanger’ for athletes living with chronic pain.
It is the first randomised trial to examine how legal, commercially available cannabis impacts anxiety symptoms.
A notable reduction in crystal meth use was observed among those who used cannabis for craving management.